Pre-emptive therapy for severe nausea and vomiting of pregnancy and hyperemesis gravidarum

Journal of Obstetrics and Gynaecology

Volumn 24, Issue 5, 2004, Pages 530-533

  Koren, G ^a   Maltepe, Caroline ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT;

ARTICLE; CONTROLLED STUDY; COUNSELING; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HYPEREMESIS GRAVIDARUM; MEDICAL ASSESSMENT; NAUSEA; PREGNANCY; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; VOMITING;

ADULT; ANTIEMETICS; DOXYLAMINE; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; FLUID THERAPY; HUMANS; HYPEREMESIS GRAVIDARUM; ONDANSETRON; PREGNANCY; PRENATAL CARE; PROSPECTIVE STUDIES; PYRIDOXINE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VITAMIN B 6;

EID: 4544226052     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/01443610410001722581     Document Type: Article

References (12)

1. Atanackovic G., Navioz Y., Moretti M.E. and Koren G. (2001) The safety of higher than standard dose of doxylaminepyridoxine (Diclectin) for nausea and vomiting of pregnancy. Journal of Clinical Pharmacology, 41, 842-845.
2. Atanackovic G., Wolpin J. and Koren G. (2001) Determinants of the need for hospital care among women with nausea and vomiting of pregnancy. Clinical and Investigative Medicine, 24, 90-93.
3. Chandra K., Magee L. and Koren G. (2002) Discordence between physical symptoms versus perception of severity by women with NVP. BMC Pregnancy Childbirth, 2, 5.
4. Einarson A., Maltepe C., Navioz Y., Kennedy D., Tan M.P. and Koren G. (2002) The safety and effectiveness of ondansetron for the treatment of nausea and vomiting (NVP) [Abstract]. International Society of Pharmacoepidemiology, August, Edinburgh, Scotland.
5. Fairweather D.V. (1968) Nausea and vomiting in pregnancy. American Journal of Obstetrics and Gynecology, 102, 135-175.
6. Gadsby R., Barnie-Alshead A.M. and Jagger C. (1993) A prospective study of nausea and vomiting during pregnancy. British Journal of General Practice, 43, 245-248.
7. Goodwin T.M. (2002) Nausea and vomiting of pregnancy: an obstetric syndrome. American Journal of Obstetrics and Gynecology, 186 (Supplement 3), S184-S186.
8. Koren G., Boskovic R., Hard M., Maltepe C., Navioz Y. and Einarson A. (2002) Motherisk - PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy. American Journal of Obstetrics and Gynecology, 185, S228-S231.
9. Mazzotta P. and Magee L.A. (2000) A risk benefit assessment of pharmacological and non pharmacological treatments of nausea and vomiting of pregnancy. Drugs, 59, 781-800.
10. Mazzotta P., Magee L.A., Maltepe C., Lifshitz A., Navioz Y. and Koren G. (1999) The perception of teratogenic risk by women with nausea and vomiting of pregnancy. Reproductive Toxicology, 13, 313-319.
11. Neutel C.I. (2000) Variation in rates of hospitalization for excessive vomiting in pregnancy by Bendectin/Diclectin use in Canada. In: Nausea and Vomiting of Pregnancy, State of the Art 2000, edited by Koren G. and Bishai R., pp. 54-59. Toronto, Motherisk Program.
12. Neutel C.I. and Johansen H.L. (1995) Measuring drug effectiveness by the case of Bendectin. Canadian Journal of Public Health, 86, 66-70.